Maresh v. DePuy Orthopaedics, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Maresh v. DePuy Orthopaedics, Inc.

Sort by

Viewing results 1‒13 of 13

Smith & Nephew PLC
Smith & Nephew in talks to buy NuVasive for over $3bn
...Before Alere, Mr Nawana spent more than 15 years at Johnson & Johnson, including time as president of its DePuy Synthes spine business....
February 8, 2019
Pharmaceuticals sector
Johnson & Johnson slips in first quarter
...The company took unspecified litigation charges, against a backdrop of continuing legal actions including compensation demands from users of its DePuy ASR artificial hip....
April 16, 2013
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
US & Canadian companies
J&J/Synthes: short on detail, high on price?
...DePuy, the division of J&J that Synthes would potentially join, made revenues of $5.6bn but supposedly lower profitability....
April 27, 2011
News in-depthUS healthcare reform
Healthcare: Left to its own devices
...William Weldon, head of J&J, says ringingly of the accord: “DePuy and Synthes together will create the most innovative and comprehensive orthopaedics business in the world, and enable us to better serve...
April 27, 2011
US healthcare reform
Deal could be cure for Johnson & Johnson
...It will solidify its dominance in orthopaedics and gain increasing power when dealing with hospitals....
April 18, 2011
Mergers & Acquisitions
Xstrata leads miners upwards on hopes of Glencore merger
...Results from DePuy, Johnson & Johnson’s orthopaedics division, and Stryker, both highlighted slowing demand for replacement knees, an important product segment for S&N....
April 20, 2011
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
FT AlphavilleNeil Hume
Bid or no bid for Smith & Nephew?
...for the US and European orthopaedic markets remains challenging....
January 10, 2011
UK companies
Judges criticise SFO role in DePuy case
...The plot – which was allegedly ordered by a more senior executive – bled money from the country’s taxpayers by inflating the price of orthopaedic products sold to the health system....
May 13, 2010
UK economy
Landmark bribery case goes to trial
...Mr Dougall was released on bail by City of Westminster magistrates’ court after being charged with conspiring with DePuy between 2002 and 2005 to pay bribes to entice Greek health officials to buy orthopaedic...
December 1, 2009
UK retail results
Retailers under pressure with fall at Next
...Smith & Nephew dropped 3.2 per cent to 532p after Johnson & Johnson, owner of DePuy Orthopaedics, posted weaker-than-expected quarterly sales....
October 13, 2009
US & Canadian companies
Zimmer faces $450m bill after legal clash
...In the case, Zimmer and four other companies – Depuy, Biomet, Stryker of the US and Smith & Nephew of the UK – were accused of paying large sums of money to surgeons as well as giving them trips and expensive...
May 16, 2008
US & Canadian companies
Implants give J&J shot in the arm
...Johnson & Johnson’s first-quarter profit rose 17 per cent, fuelled by strong growth in the US health products group’s medical devices, particularly orthopaedic implants....
April 19, 2005
Companies
Nancy Dunne: Shining future for city of spare parts
...DePuy Orthopaedics, Inc., a $3bn company and the oldest orthopaedics manufacturer in the US, designs and manufactures devices and supplies - including hip, knee, ankle, shoulder, wrist, elbow, and finger...
October 21, 2004

Previous pagePage 1 of 1Next page